RE: Do we think this is retail bailing or shorts adding?18 May 2024 07:56
Wyn
I can see your point, The simple answer is we don’t have all the information required yet the judge efficacy of AVA600 however we have some information which we are using to piecemeal together the likelihood. Information we have is that the 60yr patient had significant tumor reduction others not so much.
But not all those patients had cancers that were expected to respond. So yeah we don’t know yet but some information provided so far points towards the fact that it probably works.
That is what phase 2 is for.